Using a model of HD, Valdeolivas and coworkers47 have suggested the involvement of CB1 and CB2 cannabinoid receptors as well as receptor-independent actions in the neuroprotective effects of a CBD-enriched botanical extract. Here, CNR1 is linked to Huntington disease.